PAMS
Pictet Asset Management (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $303M | Sell |
421,772
-7,131
| -2% | -$5.12M | 0.36% | 79 |
|
|
2023
Q1 | $352M | Buy |
428,903
+120,037
| +39% | +$98.6M | 0.44% | 55 |
|
|
2022
Q4 | $178M | Sell |
308,866
-37,648
| -11% | -$21.7M | 0.26% | 117 |
|
|
2022
Q3 | $239M | Buy |
346,514
+84,405
| +32% | +$58.1M | 0.35% | 75 |
|
|
2022
Q2 | $155M | Sell |
262,109
-62,550
| -19% | -$37M | 0.22% | 143 |
|
|
2022
Q1 | $227M | Sell |
324,659
-24,467
| -7% | -$17.1M | 0.26% | 121 |
|
|
2021
Q4 | $220M | Sell |
349,126
-108,764
| -24% | -$68.7M | 0.22% | 139 |
|
|
2021
Q3 | $277M | Buy |
+457,890
| New | +$277M | 0.31% | 92 |
|